Low T Or High Risk? Testosterone Treatments And Heart Attacks

Jan 29 2014, 10:52pm CST | by

Maybe ‘Low T’ is something men may want to live with, after all. A new study finds that treatments for boosting low testosterone levels – which pervasive marketing warns can interfere with sex drive, moods and energy – may increase the risk of heart attacks in large swathes of men.

Specifically, the risk doubled during the first three months after starting therapy in men younger than 65 years old who had a history of heart disease. Similarly, the risk also doubled for all men older than 65 – those with or without heart disease – shortly after beginning treatment, according the study published in PLOS One.

At first blush, this may not seem to be heart-stopping news. Previous studies have suggested such therapies – including the widely touted AndroGel that is sold by AbbVie – can increase cardiovascular risk. In fact, a small study published in The New England Journal of Medicine three years ago reached such a conclusion (read this).

But the latest study is different and, consequently, may have the potential to change the conversation about the extent to which using testosterone treatments is desirable. And the results are prompting calls for the FDA to update product labeling (see this, this and this) in order to flag cardiovascular concerns.

Why? Unlike earlier efforts, the latest study examined a large population. The researchers culled records of 55,593 men who had been prescribed testosterone treatments, including 48,539 who were younger than 65 years old. The data was obtained from Truven Health Analytics, which aggregates patient records.

“Due to the size of our study, we were able to examine heart attacks, as opposed to a variety of cardiovascular conditions, and we were able to examine excess risk in the short term,” says William Finkle, the lead author and an epidemiologist at Consolidated Research, a statistics and software development firm. “Our study is also the first to include a substantial number of men under 65″ (here is the study).

An AbbVie spokesman did not respond to a request for comment.

The researchers also compared patients given testosterone treatments – which include the Axiron solution sold by Eli Lilly and the Androderm patch marketed by Actavis – with those given the Viagra and Cialis erectile dysfunction pills, since these are similarly prescribed for enhancing sexual performance.

Here, they found that men younger than 65 who were given testosterone boosters and had a history of heart disease were twice as likely to suffer a heart attack, relative to the impotence pills. The implication is that the increase in cardiovascular risk is due to the treatments, not the sexual behavior.

The findings come amid years of aggressive promotion of testosterone treatments. A study published last fall in the Journal of the American Medical Association noted that annual prescriptions for these elixirs rose more than five-fold from 2000 to 2011, reaching 5.3 million prescriptions. Sales totaled nearly $2 billion in 2012, according to IMS Health, the research firm.

The marketing has sometimes been controversial. Four years ago, a study in The New England Journal of Medicine found only 2 percent of men aged 40 to 80 suffered from ‘Low T,’ which is sometimes called male menopause, but the web site run by Abbott Laboratories (and now by AbbVie) was criticized for overstating the case.

And two years ago, a group of physicians and academics complained to the independent Pharmaceutical Advertising Advisory Board in Canada that an AndroGel campaign harmed public health by promoting unapproved uses and implying exaggerated effectiveness.

Consequently, the PLOS authors recommend further studies that can “assess the range of benefits and risks.” Although Sid Wolfe of Public Citizen Health Research Group believes the FDA should not wait to update the product labeling to reflect the risk of heart attacks.

“This study adds an enormous amount to what is known about the risks,” he argues. “It’s an important breakthrough and the implications are sobering, but unfortunately, there is nothing in the current labeling or the med guides for patients.”

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Irish man tests negative for Ebola virus
Dublin, Aug 22 (IANS) Laboratory test samples of an Irish man, who died after recently returning from Africa, have proved negative for Ebola virus, health authorities in Ireland said Friday.
 
 
Soyuz rocket carrying two Galileo satellites lifts off
Brussels, Aug 22 (IANS) A Soyuz rocket carrying two Galileo satellites, the fifth and sixth of Europe's Galileo global satellite navigation system, lifted off from the spaceport in French Guiana Friday, the European Space Agency (ESA) has announced.
 
 
Fresh cases of Ebola recorded in Nigeria: Official
Abuja, Aug 22 (IANS) Fresh cases of the Ebola virus disease have been recorded in Nigeria, where the highly contagious disease has already claimed five lives, Minister of Health Onyebuchi Chukwu said Friday.
 
 
Fuel cell technology gets a boost
Washington, Aug 22 (IANS) In an impetus for fuel cell technology to build "smart" cars, scientists at Stanford University have developed a low-cost, emissions-free device that uses an ordinary AAA battery to produce hydrogen by water electrolysis.
 
 
 

Latest from the Network

Irish man tests negative for Ebola virus
Dublin, Aug 22 (IANS) Laboratory test samples of an Irish man, who died after recently returning from Africa, have proved negative for Ebola virus, health authorities in Ireland said Friday. Ireland's Health Service...
Read more on Business Balla
 
Looking forward to working with Modi government: Singapore PM
Singapore, Aug 22 (IANS) Singapore Prime Minister Lee Hsien Loong Friday said his country hopes to work with India in areas of infrastructure and education, and expressed his desire to meet his Indian counterpart...
Read more on Politics Balla
 
India beat Middlesex by 95 runs
London, Aug 22 (IANS) India returned to winning ways albeit in a warm-up cricket match, registering a comfortable 95-run win over Middlesex at Lord's here Friday. India were dismantled 3-1 in the Test series,...
Read more on Sport Balla
 
Pakistan: Tensions ease as PTI agrees to resume talks (Roundup)
Islamabad, Aug 22 (IANS) Tensions in the Pakistani political landscape eased Friday with the Imran Khan-led Pakistan Tehreek-i-Insaf (PTI) party agreeing to return to the negotiating table as the Senate or the upper...
Read more on Politics Balla
 
Ukrainian rebels kill four soldiers
Kiev, Aug 22 (IANS) At least four security personnel have been killed and 23 wounded in clashes with rebels in eastern Ukraine, authorities said Friday. Four Ukrainian servicemen were killed Thursday overnight in...
Read more on Politics Balla
 
Miley Cyrus concert banned in Dominican Republic
Santo Domingo, Aug 22 (IANS/EFE) The Dominican Republic government has banned a concert where US pop star Miley Cyrus was scheduled to perform in the nation's capital Sep 13. In a notice sent to the SD Concerts and...
Read more on Celebrity Balla
 
George Clooney's ex Elisabetta Canalis engaged
George Clooney's ex Elisabetta Canalis has got engaged. The 35-year-old beauty is set to tie the knot with Brian Perri in Italy next month, as is George and his new fiancée Amal Alamuddin, after the orthopedic surgeon...
Read more on Celebrity Balla
 
Mariah Carey's jealously to blame for split?
Mariah Carey's jealousy is reportedly partly to blame for her and Nick Cannon's split. The 44-year-old singer is said to have trust issues with her spouse - with whom she has four-year-old twins Moroccan and Monroe -...
Read more on Celebrity Balla
 
Jessica Alba is 'fearless' after motherhood
Jessica Alba has become ''fearless'' since motherhood. The 33-year-old actress admits her whole perspective of her career has changed since welcoming her daughter Honor, six, and Haven, three, into the world with her...
Read more on Celebrity Balla
 
Daniel Radcliffe wants fans to forget Harry Potter
Daniel Radcliffe wants his fans to forget about 'Harry Potter'. The 25-year-old actor is currently starring in romantic comedy 'What If', and despite its success, the actor is resigned to the fact the comparisons to his...
Read more on Celebrity Balla